Literature DB >> 21920365

Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.

Rupkatha Mukhopadhyay1, Sandip Mukherjee, Budhaditya Mukherjee, Kshudiram Naskar, Dinesh Mondal, Saskia Decuypere, Bart Ostyn, Vijay Kumar Prajapati, Shyam Sundar, Jean Claude Dujardin, Syamal Roy.   

Abstract

Recent clinical isolates of Leishmania donovani from the hyperendemic zone of Bihar were characterised in vitro in terms of their sensitivity towards sodium stibogluconate in a macrophage culture system. The resulting half maximal effective concentration (EC(50)) values were compared with those of known sensitive isolates. Fifteen of the isolates showed decreased sensitivity towards SSG with an average EC(50) of 25.7 ± 4.5 μg/ml pentavalent antimony (defined as antimony resistant), whereas nine showed considerable sensitivity with an average EC(50) of 4.6 ± 1.7 μg/ml (defined as antimony sensitive). Out of those nine, seven were recent clinical isolates and the remaining two were known sensitive isolates. Compared with the antimony sensitive, resistant isolates showed enhanced expression of thiol metabolising enzymes in varying degrees coupled with increased intracellular non-protein thiol content, decreased fluorescence anisotropy (inversely proportional with membrane fluidity) and over-expression of the terminal glycoconjugates (N-acetyl-d-galactosaminyl residue). Macrophages infected with resistant but not with sensitive showed up-regulation of the ATP Binding Cassette transporter multidrug resistance protein 1 and permeability glycoprotein, while the supernatant contained abundant IL-10. The above results reinforce the notion that antimony resistant parasites have undergone a number of biochemical and biophysical changes as part of their adaptation to ensure their survival in the host.
Copyright © 2011 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21920365     DOI: 10.1016/j.ijpara.2011.07.013

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  37 in total

1.  Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.

Authors:  Maya Berg; Raquel García-Hernández; Bart Cuypers; Manu Vanaerschot; José I Manzano; José A Poveda; José A Ferragut; Santiago Castanys; Jean-Claude Dujardin; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

2.  Molecular identification of an old clinical isolate of Indian Kala-azar.

Authors:  Madhumita Manna; Supriya Khanra
Journal:  J Parasit Dis       Date:  2016-06-04

3.  Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani.

Authors:  Arpita Kulshrestha; Vasundhra Bhandari; Rupkatha Mukhopadhyay; V Ramesh; Shyam Sundar; Louis Maes; Jean Claude Dujardin; Syamal Roy; Poonam Salotra
Journal:  Parasitol Res       Date:  2012-12-13       Impact factor: 2.289

4.  Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1.

Authors:  Budhaditya Mukherjee; Rupkatha Mukhopadhyay; Bijoylaxmi Bannerjee; Sayan Chowdhury; Sandip Mukherjee; Kshudiram Naskar; Uday Sankar Allam; Dipshikha Chakravortty; Shyam Sundar; Jean-Claude Dujardin; Syamal Roy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

5.  Elucidation of cellular mechanisms involved in experimental paromomycin resistance in Leishmania donovani.

Authors:  Vasundhra Bhandari; Shyam Sundar; Jean Claude Dujardin; Poonam Salotra
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

6.  Saraca asoca seed extract treatment recovers the trace elements imbalances in experimental murine visceral leishmaniasis.

Authors:  Sangita Lahiry; Debasish Bhattacharyya; Anindita Chakraborty; Mathummal Sudarshan; Madhumita Manna
Journal:  J Parasit Dis       Date:  2019-10-26

7.  Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent.

Authors:  Hideo Imamura; Tim Downing; Frederik Van den Broeck; Mandy J Sanders; Suman Rijal; Shyam Sundar; An Mannaert; Manu Vanaerschot; Maya Berg; Géraldine De Muylder; Franck Dumetz; Bart Cuypers; Ilse Maes; Malgorzata Domagalska; Saskia Decuypere; Keshav Rai; Surendra Uranw; Narayan Raj Bhattarai; Basudha Khanal; Vijay Kumar Prajapati; Smriti Sharma; Olivia Stark; Gabriele Schönian; Harry P De Koning; Luca Settimo; Benoit Vanhollebeke; Syamal Roy; Bart Ostyn; Marleen Boelaert; Louis Maes; Matthew Berriman; Jean-Claude Dujardin; James A Cotton
Journal:  Elife       Date:  2016-03-22       Impact factor: 8.140

8.  Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.

Authors:  Deepak Kumar Deep; Ruchi Singh; Arpita Kulshrestha; Saima Wajid; Poonam Salotra
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

9.  Flavone-resistant Leishmania donovani overexpresses LdMRP2 transporter in the parasite and activates host MRP2 on macrophages to circumvent the flavone-mediated cell death.

Authors:  Sayan Chowdhury; Rupkatha Mukhopadhyay; Sourav Saha; Amartya Mishra; Souvik Sengupta; Syamal Roy; Hemanta K Majumder
Journal:  J Biol Chem       Date:  2014-04-04       Impact factor: 5.157

10.  Simple colorimetric trypanothione reductase-based assay for high-throughput screening of drugs against Leishmania intracellular amastigotes.

Authors:  Erika van den Bogaart; Gerard J Schoone; Paul England; Dorien Faber; Kristina M Orrling; Jean-Claude Dujardin; Shyam Sundar; Henk D F H Schallig; Emily R Adams
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.